Pharmacological implications in the switch from acute to chronic inflammation Franco DallegriLuciano Ottonello OriginalPaper Pages: 159 - 171
Effects of oxaprozin and of other 2-arylpropionic acid derivatives on nuclear factor κB(NF-κB) activation Maurizio Bevilacqua OriginalPaper Pages: 173 - 183
Recent pharmacodynamic and pharmacokinetic findings on oxaprozin K. D. RainsfordH. OmarR. W. Seabrook OriginalPaper Pages: 185 - 239
A critical assessment of oxaprozin clinical profile in rheumatic diseases Walter F. KeanRobert KeanW. Watson Buchanan OriginalPaper Pages: 241 - 284